CytomX Therapeutics, Inc.

BARCLAYS PLC CTMX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

336,525

Value ($000)

1,434

Weight

0.0%

2019 Q4 - 2025 Q4 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	1,434	0.0%	336,525	12/31/2025
2025 Q3	3/31/2026	5	0.0%	1,490	9/30/2025
2025 Q2	2/27/2026	0	0.0%	2	6/30/2025
2025 Q1	3/17/2026	0	0.0%	2	3/31/2025
2022 Q1	5/16/2022	28	0.0%	10,528	3/31/2022
2021 Q4	2/14/2022	341	0.0%	78,730	12/31/2021
2021 Q3	11/9/2021	564	0.0%	110,853	9/30/2021
2021 Q2	8/13/2021	802	0.0%	126,781	6/30/2021
2021 Q1	5/13/2021	1,062	0.0%	137,304	3/31/2021
2020 Q4	2/11/2021	589	0.0%	90,014	12/31/2020
2020 Q3	11/12/2020	197	0.0%	29,540	9/30/2020
2020 Q2	8/12/2020	289	0.0%	34,662	6/30/2020
2020 Q1	5/13/2020	179	0.0%	23,367	3/31/2020
2019 Q4	2/10/2020	452	0.0%	54,293	12/31/2019